NCT04519385View on ClinicalTrials.gov

Toclizumam Versus Dexamethasone in Severe Covid-19 Cases

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

July 1, 2020

Study Completion Date

August 5, 2020

Conditions
Pneumonia, Viral
Interventions
DRUG

Tocilizumab

Tocilizumab therapy

DRUG

Dexamethasone

dexamethsone pulse therapy

Trial Locations (1)

83523

Qena faculty medicine, Qina

All Listed Sponsors
lead

South Valley University

OTHER

NCT04519385 - Toclizumam Versus Dexamethasone in Severe Covid-19 Cases | Biotech Hunter | Biotech Hunter